Amgen Total Non-Operating Income/Expense 2010-2024 | AMGN
Amgen total non-operating income/expense for the twelve months ending September 30, 2024 was $-1.539B, a 1365.71% increase year-over-year.
- Amgen annual total non-operating income/expense for 2023 was $-0.042B, a 98.11% decline from 2022.
- Amgen annual total non-operating income/expense for 2022 was $-2.22B, a 136.67% increase from 2021.
- Amgen annual total non-operating income/expense for 2021 was $-0.938B, a 6.76% decline from 2020.